Define the care pathway for lung cancer in the US and Asia to help identify pivotal informational/decision points.
The pathways proved more complex than expected, including many “if…then…” data points where pathways could pivot.
We evolved the US discussion guide over the course of interviews to drill down into the fine points of the care path. Then we used the US path as a grounding point to identify similarities and differences in China and Japan.
The care pathway chart proved to be a valuable tool to both understand and communicate about the pathway going forward.